GO:0006571 L-tyrosine biosynthetic process: Aromatic Amino Acid Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006571 describes the biological process that produces L-tyrosine, an aromatic amino acid required for protein synthesis and precursor to hormones, neurotransmitters, and pigments [1,2].
• In plants and microbes, L-tyrosine biosynthesis occurs via the shikimate pathway, a seven-step route that converts erythrose-4-phosphate and phosphoenolpyruvate into chorismate and then tyrosine.
• In mammals, L-tyrosine is conditionally essential; it is obtained from diet or by hydroxylation of phenylalanine, and its biosynthetic process is tightly regulated.
• Key enzymes include DAHPS, EPSPS, chorismate mutase, prephenate dehydrogenase, and tyrosine aminotransferase, which are targets for metabolic engineering and herbicide design [1,4].
• Dysregulation of L-tyrosine biosynthesis and catabolism is linked to melanoma, neuroblastoma, and metabolic disorders, making it a focus for diagnostic and therapeutic research [3,6,7].
• CRISPR-based knockout, knock-in, and overexpression models enable causal interrogation of genes in the L-tyrosine biosynthetic process for drug discovery and synthetic biology [4,8].
Description
L-tyrosine biosynthetic process (GO:0006571) is defined as the chemical reactions and pathways resulting in the formation of tyrosine, an aromatic amino acid, 2-amino-3-(4-hydroxyphenyl)propanoic acid. This process is fundamental to all domains of life because tyrosine serves as a building block for proteins and as a precursor for diverse specialized metabolites, including neurotransmitters, hormones, and pigments [1,2]. In plants and microorganisms, the shikimate pathway provides the primary route for aromatic amino acid biosynthesis, and its enzymes are validated targets for herbicides and antimicrobials. In mammals, L-tyrosine is conditionally essential; it can be synthesized from phenylalanine via phenylalanine hydroxylase or obtained from the diet, and its availability influences melanogenesis and catecholamine production. Understanding the L-tyrosine biosynthetic process is therefore central to metabolic engineering, cancer biology, and neurochemistry [2,4,6].
L-tyrosine biosynthetic process At A Glance
| GO ID | GO:0006571 |
|---|---|
| GO term | L-tyrosine biosynthetic process |
| Ontology | biological_process |
| Synonym | tyrosine anabolism, tyrosine biosynthesis, tyrosine formation, tyrosine synthesis |
| Major function | Synthesis of L-tyrosine from precursors such as chorismate or phenylalanine |
| Key pathways | Shikimate pathway (plants/microbes); phenylalanine hydroxylation (mammals) |
| Key enzymes | DAHPS, EPSPS, chorismate mutase, prephenate dehydrogenase, tyrosine aminotransferase, phenylalanine hydroxylase |
| Organisms | Plants, bacteria, fungi, mammals |
| Research relevance | Metabolic engineering, herbicide design, melanoma and neuroblastoma biology, neurotransmitter synthesis |
What Is GO:0006571?
GO:0006571, L-tyrosine biosynthetic process, encompasses the enzymatic steps that build L-tyrosine from simpler precursors. In plants and microbes, this involves the shikimate pathway, which converts erythrose-4-phosphate and phosphoenolpyruvate into chorismate, followed by branch-specific reactions that yield tyrosine. In mammals, the term covers the hydroxylation of L-phenylalanine to L-tyrosine, catalyzed by phenylalanine hydroxylase, as well as any salvage or interconversion reactions that generate tyrosine. The process is essential for protein synthesis and for the production of tyrosine-derived molecules such as L-DOPA, melanin, and thyroid hormones [2,7].
Why Is L-tyrosine biosynthetic process Important in Cell Biology?
The L-tyrosine biosynthetic process is a cornerstone of primary and specialized metabolism. It supplies tyrosine for protein synthesis and for the production of catecholamines, thyroid hormones, and melanin, thereby impacting neurotransmission, pigmentation, and energy balance [2,7]. In agriculture, the shikimate pathway enzymes are targets of broad-spectrum herbicides such as glyphosate, and engineering tyrosine biosynthesis can enhance nutritional quality and stress tolerance in crops. In biotechnology, microbial production of L-tyrosine is optimized for industrial synthesis of pharmaceuticals and food additives [4,8]. In medicine, dysregulated tyrosine metabolism is associated with melanoma progression and is exploited in PET imaging of brain tumors using radiolabeled tyrosine analogs [3,6].
• Provides L-tyrosine for protein synthesis and for precursors of dopamine, norepinephrine, epinephrine, and thyroid hormones.
• Shikimate pathway enzymes are targets for herbicides and antimicrobials, making the process agriculturally and clinically relevant.
• Microbial L-tyrosine production is used for industrial biosynthesis of L-DOPA, melanin, and other value-added compounds [2,8].
• Melanoma cells rely on L-tyrosine transport and metabolism for melanin synthesis, linking the process to cancer biology [3,7].
• Radiolabeled L-tyrosine analogs are used in PET imaging of brain tumors, reflecting the importance of tyrosine uptake and metabolism.
• Metabolic engineering of Escherichia coli for L-tyrosine overproduction supports sustainable chemical manufacturing.
• Mutations in enzymes of tyrosine catabolism cause metabolic disorders such as tyrosinemia, highlighting the need for balanced biosynthesis.
• CRISPR screens can identify genes that regulate L-tyrosine biosynthesis, offering targets for therapeutic intervention [4,8].
What Happens During L-tyrosine biosynthetic process?
Shikimate pathway: from central metabolites to chorismate
In simple terms: Plants and bacteria build aromatic amino acids through a seven-step assembly line called the shikimate pathway.
The shikimate pathway converts erythrose-4-phosphate and phosphoenolpyruvate into chorismate through seven enzymatic steps, including DAHPS, DHQS, SDH, and EPSPS. This pathway is absent in animals, making it an attractive target for herbicides and antimicrobials. Chorismate is the branchpoint precursor for tyrosine, phenylalanine, and tryptophan.
Chorismate to prephenate and 4-hydroxyphenylpyruvate
In simple terms: Chorismate is rearranged and then modified to form a tyrosine-specific intermediate.
Chorismate mutase converts chorismate to prephenate, which is then oxidatively decarboxylated by prephenate dehydrogenase to yield 4-hydroxyphenylpyruvate. In some organisms, a bifunctional chorismate mutase-prephenate dehydrogenase enzyme catalyzes both steps. This branch is specific to tyrosine biosynthesis and is regulated by feedback inhibition.
Transamination to L-tyrosine
In simple terms: A nitrogen group is added to the intermediate to make the final amino acid, tyrosine.
Tyrosine aminotransferase (TAT) catalyzes the reversible transamination of 4-hydroxyphenylpyruvate to L-tyrosine using glutamate as the amino donor. In mammals, tyrosine is also generated by phenylalanine hydroxylase, which hydroxylates L-phenylalanine to L-tyrosine. This reaction is critical for maintaining tyrosine pools when dietary intake is insufficient.
Microbial and plant metabolic engineering
In simple terms: Scientists tweak the pathway in microbes and plants to produce more tyrosine for industrial or nutritional use.
Systems metabolic engineering of Escherichia coli has achieved high-titer L-tyrosine production from glucose syrup by optimizing the shikimate pathway and reducing feedback inhibition. Whole-cell biotransformation using tyrosine phenol-lyase offers an alternative route for L-tyrosine synthesis from phenol and pyruvate. In plants, overexpression of shikimate pathway genes can enhance aromatic amino acid content and stress tolerance.
Regulation of tyrosine biosynthesis
In simple terms: The cell controls how much tyrosine it makes by adjusting enzyme activity and gene expression.
In bacteria, the shikimate pathway is regulated by feedback inhibition of DAHPS and other enzymes by tyrosine and phenylalanine. In mammals, phenylalanine hydroxylase activity is regulated by substrate availability and phosphorylation, and tyrosine hydroxylase controls the first step of catecholamine synthesis. Transcriptional regulation of tyrosine biosynthetic genes responds to nutritional and hormonal signals [1,7].
Key Genes Involved in GO:0006571 L-tyrosine biosynthetic process
The following genes and enzymes are core components of the L-tyrosine biosynthetic process across model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| aroG (DAHPS) | First enzyme of shikimate pathway; condenses E4P and PEP | Target for metabolic engineering and herbicide design [1,4] |
| aroA (EPSPS) | Catalyzes condensation of shikimate-3-phosphate and PEP | Target of glyphosate; engineering for herbicide resistance |
| aroK/aroL | Shikimate kinases that phosphorylate shikimate | Pathway flux control in bacteria |
| pheA | Bifunctional chorismate mutase-prephenate dehydratase | Competes with tyrosine branch; knockout improves tyrosine yield |
| tyrA | Bifunctional chorismate mutase-prephenate dehydrogenase | Directs flux to tyrosine; feedback-regulated [1,4] |
| tyrB | Tyrosine aminotransferase (broad specificity) | Transaminates 4-HPP to tyrosine |
| TAT | Tyrosine aminotransferase in mammals | Links tyrosine biosynthesis to gluconeogenesis and neurotransmitter synthesis |
| PAH | Phenylalanine hydroxylase | Converts phenylalanine to tyrosine; mutations cause PKU |
| TH | Tyrosine hydroxylase | Rate-limiting for catecholamine synthesis; uses tyrosine |
| TYR | Tyrosinase | Oxidizes tyrosine to DOPA and melanin in melanocytes [3,7] |
| SLC7A11 | Cystine/glutamate antiporter | Influences tyrosine uptake and redox balance in cancer |
| SLC16A10 | Aromatic amino acid transporter | Mediates tyrosine transport in melanoma and brain [3,6] |
| GOT1 | Aspartate aminotransferase | Supplies amino groups for transamination |
| CS | Chorismate synthase | Final step of shikimate pathway |
| CM | Chorismate mutase | Branchpoint enzyme for tyrosine and phenylalanine |
| PDH | Prephenate dehydrogenase | Oxidative decarboxylation to 4-HPP |
| HPPD | 4-hydroxyphenylpyruvate dioxygenase | Catabolic enzyme; inhibitor target in medicine |
| MIF | Macrophage migration inhibitory factor | Potential link to tyrosine metabolism in cancer |
How Is L-tyrosine biosynthetic process Regulated?
The L-tyrosine biosynthetic process is regulated at multiple levels. In bacteria, the shikimate pathway is controlled by feedback inhibition of DAHPS and other enzymes by tyrosine and phenylalanine, and by transcriptional attenuation of the aro operon. In plants, the pathway is regulated by developmental and environmental signals, including light and stress. In mammals, phenylalanine hydroxylase is regulated by substrate availability, phosphorylation, and allosteric effectors, while tyrosine hydroxylase is controlled by feedback inhibition and phosphorylation. These regulatory mechanisms ensure that tyrosine supply matches demand for protein synthesis and specialized metabolism [1,7].
L-tyrosine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PAH | Phenylketonuria; impaired tyrosine synthesis | Knockout mouse or patient-derived iPSCs |
| TYR | Melanoma; pigmentation disorders | Melanoma cell lines with TYR knockout |
| SLC7A11 | Cancer; ferroptosis regulation | Cancer cell lines with overexpression or knockout |
| SLC16A10 | Brain tumors; tyrosine transport | Glioma cells with tagged knock-in for imaging |
| HPPD | Tyrosinemia type III; metabolic disorder | Liver organoids with point mutations |
Melanoma and pigmentation disorders
Melanoma cells exhibit increased L-tyrosine transport and tyrosinase activity to support melanin synthesis, making the L-tyrosine biosynthetic and metabolic pathways relevant to pigmentation disorders and melanoma progression [3,7]. L-tyrosine and L-DOPA act as hormone-like regulators of melanocyte function, influencing proliferation and differentiation. Targeting tyrosine transport or metabolism may offer therapeutic strategies for melanoma.
Neuroblastoma and brain tumors
Radiolabeled L-tyrosine analogs such as O-(2-[18F]-fluoroethyl)-L-tyrosine (FET) are used in PET imaging of brain tumors, reflecting increased tyrosine uptake and metabolism in neurooncology. This diagnostic application highlights the importance of tyrosine transport and biosynthetic pathways in cancer cells.
Metabolic disorders: phenylketonuria and tyrosinemia
Mutations in phenylalanine hydroxylase cause phenylketonuria (PKU), in which tyrosine becomes essential because it cannot be synthesized from phenylalanine. Conversely, defects in tyrosine catabolism lead to tyrosinemia, illustrating the need for balanced tyrosine biosynthesis and degradation.
Infectious disease and antimicrobial targets
The shikimate pathway is essential in bacteria, fungi, and plants but absent in humans, making its enzymes attractive targets for antimicrobial and herbicide development. Inhibitors of DAHPS, EPSPS, and chorismate mutase have been explored as antibacterial agents.
From L-tyrosine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does knockout of tyrA reduce L-tyrosine production? | E. coli tyrA knockout strain |
| Can point mutation in aroG relieve feedback inhibition? | Site-directed mutagenesis of aroG in E. coli |
| Does knock-in of a fluorescent tag affect TAT localization? | CRISPR knock-in of GFP-TAT in hepatocytes |
| Does overexpression of PAH increase tyrosine synthesis? | Lentiviral overexpression in hepatoma cells |
| Which genes regulate tyrosine biosynthesis in melanoma? | Genome-wide CRISPR knockout screen in melanoma cells |
| Can tyrosine production be enhanced by pathway optimization? | Metabolic engineering of E. coli with multiple gene knockouts [4,8] |
How to Study the L-tyrosine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of biosynthetic genes | Expression profiling in engineered strains |
| LC-MS metabolomics | Intracellular L-tyrosine and intermediates | Quantifying pathway flux |
| 13C flux analysis | Carbon flow through shikimate pathway | Metabolic engineering optimization |
| Enzyme activity assays | Catalytic activity of DAHPS, CM, PDH, TAT | Characterizing mutant enzymes |
| Western blot | Protein expression and modification | Validating knockout or overexpression |
| PET imaging | Tyrosine uptake and metabolism in vivo | Brain tumor diagnosis |
| CRISPR screen | Genes affecting tyrosine production | Identifying novel regulators |
| Whole-cell biotransformation | Conversion of precursors to L-tyrosine | Industrial production |
Genomic and transcriptomic profiling
RNA-seq and microarray analysis can quantify expression of shikimate pathway genes and tyrosine biosynthetic enzymes under different conditions [1,4]. CRISPR screens coupled with sequencing identify genes that affect tyrosine production or utilization.
Metabolomics and flux analysis
LC-MS and GC-MS metabolomics quantify L-tyrosine and intermediates such as prephenate and 4-hydroxyphenylpyruvate, while 13C flux analysis traces carbon flow through the pathway [1,4]. These methods are essential for metabolic engineering.
Enzymatic assays and protein biochemistry
In vitro enzyme assays measure activities of DAHPS, chorismate mutase, prephenate dehydrogenase, and tyrosine aminotransferase. Western blotting and immunoprecipitation assess protein levels and interactions.
Imaging and tracer studies
PET imaging with 18F-FET visualizes tyrosine transport and metabolism in brain tumors. Fluorescent reporters and tagged proteins enable live-cell imaging of pathway enzymes.
How CRISPR Can Be Used to Study GO:0006571 L-tyrosine biosynthetic process
Knockout
CRISPR knockout of tyrA, aroG, or TAT can abolish or reduce L-tyrosine biosynthesis, enabling studies of auxotrophy and pathway dependence. In melanoma cells, knockout of TYR or SLC7A11 affects pigmentation and redox balance.
Point Mutation
Point mutations in aroG or tyrA can relieve feedback inhibition and increase tyrosine production, as demonstrated in engineered E. coli. Disease-associated mutations in PAH can be modeled to study PKU.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci allows real-time tracking of enzymes such as TAT or PAH. Knock-in of reporter genes can monitor pathway activity in live cells.
Overexpression
Overexpression of shikimate pathway genes or PAH can enhance L-tyrosine production in microbial or mammalian cells [4,7]. Inducible overexpression systems enable dose-dependent control of pathway flux.
How EDITGENE Supports L-tyrosine biosynthetic process Research
Researchers studying L-tyrosine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or metabolic engineering. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for L-tyrosine biosynthetic process research.
Frequently Asked Questions About L-tyrosine biosynthetic process
What is L-tyrosine biosynthetic process?
It is the set of biochemical reactions that produce L-tyrosine, an aromatic amino acid, from precursors such as chorismate or phenylalanine [1,7].
What genes are involved in L-tyrosine biosynthetic process?
Key genes include aroG, aroA, tyrA, tyrB, TAT, and PAH, which encode enzymes of the shikimate pathway or phenylalanine hydroxylation [1,7].
Where does L-tyrosine biosynthesis occur in cells?
In plants and microbes, it occurs in the cytosol via the shikimate pathway; in mammals, phenylalanine hydroxylation occurs mainly in the liver [1,7].
Why is L-tyrosine important for melanoma?
Melanoma cells use L-tyrosine for melanin synthesis and as a regulator of melanocyte function, making the pathway relevant to pigmentation and cancer [3,7].
How is L-tyrosine produced industrially?
Microbial fermentation using engineered E. coli or whole-cell biotransformation with tyrosine phenol-lyase is used for industrial L-tyrosine production [4,8].
What diseases are linked to L-tyrosine biosynthesis?
Phenylketonuria, tyrosinemia, melanoma, and neuroblastoma are associated with defects or dysregulation of tyrosine metabolism [6,7].
Can CRISPR be used to study L-tyrosine biosynthesis?
Yes, CRISPR knockout, knock-in, and overexpression models enable functional studies of genes in the pathway [4,7].
What is the shikimate pathway?
It is a seven-step metabolic route in plants and microbes that produces chorismate, the precursor for aromatic amino acids including tyrosine.
How is L-tyrosine biosynthesis regulated?
It is regulated by feedback inhibition of enzymes, transcriptional control, and substrate availability [1,7].
What methods are used to measure L-tyrosine biosynthesis?
LC-MS metabolomics, enzyme assays, RNA-seq, and PET imaging with radiolabeled tyrosine analogs are commonly used [1,4,6].
Conclusion
The L-tyrosine biosynthetic process (GO:0006571) is a fundamental metabolic pathway that supplies tyrosine for protein synthesis and specialized metabolism across organisms. Its enzymes are targets for herbicides, antimicrobials, and metabolic engineering, and its dysregulation is implicated in melanoma, neuroblastoma, and metabolic disorders [1,2,7]. Advances in CRISPR-based models and metabolomics continue to illuminate the regulation and therapeutic potential of this pathway [4,6].
References
- 1. Maeda H et al.. 2012. The shikimate pathway and aromatic amino Acid biosynthesis in plants.. Annu Rev Plant Biol 63:73-105 PMID: 22554242
- 2. Tan X et al.. 2020. Recent advances in biocatalytic derivatization of L-tyrosine.. Appl Microbiol Biotechnol 104(23):9907-9920 PMID: 33067683
- 3. Jara JR et al.. 1990. Transport of L-tyrosine by B16/F10 malignant melanocytes: characterization of the process.. Pigment Cell Res 3(6):290-6 PMID: 1983230
- 4. Chen Z et al.. 2025. Systems metabolic engineering and process optimization for efficient l-tyrosine production from high-purity glucose syrup in Escherichia coli.. Bioresour Technol 425:132306 PMID: 40015532
- 6. Stegmayr C et al.. 2019. O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results.. Curr Radiopharm 12(3):201-210 PMID: 30636621
- 7. Slominski A et al.. 2012. L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.. Pigment Cell Melanoma Res 25(1):14-27 PMID: 21834848
- 8. Xu S et al.. 2019. Production of L-tyrosine using tyrosine phenol-lyase by whole cell biotransformation approach.. Enzyme Microb Technol 131:109430 PMID: 31615664
